May 11, 2022 / 12:30PM GMT
Operator
Greetings, and welcome to Catalyst Pharmaceuticals CPRX First Quarter 2022 Financial Results Conference Call (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Ali Grande, CFO of Catalyst Pharmaceuticals. Please go ahead, ma'am.
Alicia Grande - Catalyst Pharmaceuticals, Inc. - CAO, VP, Treasurer & CFO
Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's first quarter 2022 financial results and corporate highlights. Leading the call today is Patrick McEnany, Chairman and Chief Executive Officer. We are also joined by Dr. Steven Miller, our Chief Operating Officer and Chief Scientific Officer; and Jeffrey Del Carmen, our Chief Commercial Officer. Further, for the Q&A session, we'll have Dr. Gary Ingenito, our Chief Medical and Regulatory Officer; and Brian Elsbernd, our Chief Legal and Compliance Officer.
Before we begin, I would like to remind you that in our presentation this morning and in the Q&A session, we will make
Q1 2022 Catalyst Pharmaceuticals Inc Earnings Call Transcript
May 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers